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Abstract
Health services and policy research (HSPR) represent a multidisciplinary field which integrates knowledge from health 
economics, health policy, health technology assessment, epidemiology, political science among other fields, to evaluate 
decisions in health service delivery. Health service decisions are informed by evidence at the clinical, organizational, 
and policy level, levels with distinct, managerial drivers. HSPR has an evolving discourse spanning knowledge 
translation, linkage and exchange between research and decision-maker partners and more recently, implementation 
science and learning health systems. Local context is important for HSPR and is important in advancing health reform 
practice. The amounts and configuration of national investment in this field remain important considerations which 
reflect priority investment areas. The priorities set within this field or research may have greater or lesser effects and 
promise with respect to modernizing health services in pursuit of better value and better population outcomes. Within 
Canada an asset map for HSPR was published by the national HSPR research institute. Having estimated publicly-
funded research spending in Canada, we sought identify best available comparable estimates from the United States 
and the United Kingdom. Investments from industry and charitable organizations were not included in these numbers. 
This commentary explores spending by the United States, Canada, and the United Kingdom on HSPR as a fraction 
of total public spending on health and the importance of these respective investments in advancing health service 
performance. Proposals are offered on the merits of common nomenclature and accounting for areas of investigation 
in pursuit of some comparable way of assessing priority HSPR investments and suggestions for earmarking such 
investments to total investment in health services spending. 
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Evolution of Health Services and Policy Research
Health services and policy research (HSPR) evaluates 
processes related to the organization, management, delivery, 
regulation and finance of healthcare services. It is an 
interdisciplinary research area that combines knowledge 
from multiple fields: health economics, health policy, 
health technology assessment, clinical epidemiology and 
biostatistics, political science, sociology, law, among other 
fields.1 Canada, the United Kingdom and the United States 
have distinct but overlapping HSPR evolutions. Early work in 
the United Kingdom in HSPR was rooted in the comparative 
work of Sir William Petty who compared outcomes in London 
and Paris hospitals. An excellent historiography of health 
services in the United States characterizes its origins within 
the National Institutes of Health (NIH).2
Following other policy fields, HSPR evolved with a focus on 
knowledge translation between researchers and decision-
makers. This allowed for common ground on evolving 
priorities with a view to managing priority HSPR research 
initiatives. Canada, following comparable efforts in the 
United Kingdom, began a series of ‘listening’ exercises 
involving researchers, funders and decision-makers in 2001 
to set common priorities for HSPR.3 A decade later (2013-
2014), the Canadian Institute for Health Services and Policy 
Research (IHSPR) built a topography of national spending 
on HSPR, following a consultation with funders, decision-
makers, researchers and thought leaders.1 Canada’s national 
health research agency (CIHR) groups investments into four 
spending pillars (biomedical, clinical, health services and 
policy, and population and public health).4 HSPR wins the 
least amount of public funds among these pillars, despite the 
promise of HSPR as a key agent of value in health services 
modernization. Tamblyn et al have noted that in 2010, HSPR 
was the least funded pillar, having only 6.2% of health research 
funds at CIHR. This only grew to 7.5% in the year 2015-2016, 
a modest investment increase.5
Evolution of Health Services and Policy Research in Canada
Canada’s IHSPR1 has evolved its program in the last 3 years 
to align with a more applied, provincially driven, research 
agenda reflecting reform imperatives. Figure shows the 
notional evolution of HSPR research in Canada from 1948-
20154 with the aspiration of moving from an individual, 
research contribution model to one which cumulatively 
informs a learning health system model of continuous self-
improvement.6 The field matured in Canada with investments 
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from an early national health grant that preceded the 
Canadian Health Services Research Foundation, IHSPR and 
the emergence of a national Association for Health Services 
and Policy Research to advance the field.7
In 2014-2016, CIHR’s IHSPR created a pan-Canadian Vision 
and Strategy for HSPR. The objective of the first phase 
was to analyse the current state of HSPR investments and 
account for funding investments in terms of assets, resources, 
strengths, opportunities and gaps.4 IHSPR identified 15 
spending categories in its most recent Listening for Direction 
report. This initiative showed that in the fiscal year of 2010, 
government only sources invested $131 869 754 million 
Canadian dollars. This project mapped the flow of HSPR 
investments by spending categories, geography and recipient 
institutions.1 
Estimating Public Spending in HSPR in the United Kingdom, 
the United States, and Canada
HSPR research topography is influenced by and in turn 
influences evolving local policies and delivery systems. 
Modernizing a health service requires consideration of 
research funding within a health system.8 Estimates of 
the available public spend on HSPR in Canada, the United 
States and the United Kingdom were developed to compare 
respective research investments.4,9,10 These estimates do have 
limitations due to country variation in categorical definitions 
of HSPR. Publicly available documents were used to calculate 
the government-only per capita investment on HSPR. 
This per capita calculation involved taking the total HSPR 
research spending by government only for each of the 3 
countries standardized to US dollars for the 2010 fiscal year 
and dividing it by the World Bank population for the same 
year[1]. The per capita estimate was verified with an expert 
from each country for external validity[2]. The pan-Canadian 
Vision and Strategy for HSPR validated Canadian spending. 
Within the United Kingdom, the UK Research and Analysis 
report was used to estimate spending on HSPR.9 For the 
United States, Academy Health provided federal funding 
tables developed by Denis and Associates.10 
Cross Comparison of HSPR Spending in Canada, the 
United States and the United Kingdom
As seen in Table in fiscal year 2010, the United States had 
the greatest per capita investment of US$6.46, representing 
federal public spending on HSPR. Canada spent much less 
than the United States, spending US$3.76 per capita. The 
United Kingdom spent US$2.90 per capita on HSPR.
We were unable to identify comprehensive estimates of the 
United States, state-only investment in HSPR, so the United 
States is certainly an underestimate of their public HSPR 
spending. Our estimates do not take into account funding by 
private sources, charities or municipal sources in the three 
countries[3]. 
Recent reform within the United States under the Affordable 
Care Act (ACA) provide a partial context for why their 
HSPR spending leads the pack.13 The ACA has driven 
large investments in HSPR enabling initiatives including 
comparative effectiveness studies. Neither Canada nor the 
United Kingdom have seen comparable HSPR investments. 
There is a pressing need to track the impact of increased 
investments in HSPR on improvements in health system 
performance and quality. Recent Canadian reforms in CIHR 
funding have transitioned funds to through the Strategy for 
Patient Oriented Research Outcomes to more actively support 
provincial priorities.14 Prior to 2010, the United Kingdom 
had a surge in health service investments under the Blair 
government which has been associated with improvements 
in quality over time. One need only look at the performance 
of the three countries in US Commonwealth Fund surveys 
and the Organization for Economic Co-operation and 
Development (OECD) studies to see that the United Kingdom 
focus on improving health sector performance has shown 
promise.15-17 It remains a challenge to understand, in the 
absence of better comparative data, why the major US HSPR 
spending yields relatively mixed results, why Canada fares 
less well in international comparisons than might be expected 
relative to its spend on HSPR. Is it possible that the United 
States and Canada as federated states are more challenged 
to apply population-based HSPR derived service standards 
across subnational jurisdictions than it might be in a unitary 
state like the United Kingdom with one National Health 
Service (NHS)? 
What does appear clear is that high performing institutions 
appear to be well governed and managed with better 
quality and performance outcomes.18 The challenge is to get 
better comparative data to understand the impact of HSPR 
investments and how they interact with intentional managerial 
and governance processes to improve performance over 
time within specific organizational, managerial and policy 
contexts. This will help us understand how HSPR can best be 
deployed in building capacity for improvement and quality.19 
Some work is underway through IHSPR in Canada to build 
better indicators for impact and attribution building on the 
Canadian Academy of Health Science report on research 
metrics including return on investment[4].
 
Improving Comparability: A Modest Proposal 
The respective political and economic contexts shed some 
light on the HSPR spending data in the three countries, with 
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Figure 1. Notional Growth and Evolution of Health Services and Policy Research in Canada With 
Shift to Learning Health Systems.4 
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spending on HSPR reflecting the ordering of healthcare 
spending per capita. Don Berwick recently outlined a 
chartered agenda for health services and policy. His top two 
topics aligned with the ‘triple aim’ framework of better health 
for individuals, lower per capita costs (better value), and 
better health for populations alongside better ways to involve 
doctors in change and creating transitional business models 
for hospitals.13 
HSPR has emerged as a mature field of study tied to 
evaluating and supporting implementation of health services 
improvements for both individuals and the health of the 
population. We suggest that HSPR researchers, funders 
and policy-makers consider a simple proposal. We need 
leadership to advance an international forum for cooperative 
exchange among voluntary, OECD national research agencies 
to track and advance common nomenclature, definition 
and categorization of HSPR in different national contexts. 
This is particularly important with healthcare spending 
consuming ever larger fractions of gross domestic product 
(GDP) and with questions of value looming. Such a forum 
could calculate the spend and work to track reform impacts 
arising from this work. There does appear to be some work 
emerging throughout the European Commission on health 
systems, which is pursuing some common effort on health 
services definitions.20 Policy-makers and research funding 
agencies can learn from comparative effects of HSPR 
investments across their health systems. While research is 
only one input to policy, such a collaborative effort of HSPR 
funders, research leaders and policy-makers would help our 
respective jurisdictions begin to untangle the complex science 
of attribution linking HSPR investment strategies and health 
system improvements. 
As we work to untangle some of the attribution of HSPR 
investments in health outcomes, a case could be made for 
more precise earmarking and targeting of HSPR funds 
as a fraction of health spending, where the causal science 
might suggest. There is a well-respected UK precedent for 
earmarking 1.5% of health spending for research as was done 
following the prescient Culyer Report on Supporting Research 
and Development in the NHS more than two decades ago.21 
A better alignment of HSPR definitions, a robust earmarking 
of spending for those effective HSPR investments which are 
instrumental in yielding better health outcomes, along with 
healthy competition on HSPR across nations can only lead to 
better performance in our health systems. 
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Endnotes
[1]  The conversion rate for currency was applied for all monetary values from 
CDN to USD and British Pounds to USD. The Canadian FOREX conversion 
calculator was used for this task:  http://www.canadianforex.ca/currency-
converter.
[2] For the United States, Denis and Associates provided estimates of public 
spending in HSPR. For Canada, Sullivan & Associates verified estimates for 
public spending in HSPR. For the United Kingdom, Dr. James Carter, the 
Evaluation Officer at the Medical Research Council verified the numbers within 
the UK research and analysis document.
[3]  In all three countries, HSPR enjoys varying levels of support from charities, 
hospital associated foundations, and even direct spending on consulting 
services. We focused on government only spend on HSPR since it is most 
easily verifiable and the other charitable and private sources of HSPR funds, 
while not trivial, are not reliably captured or aggregated in comparable ways. 
[4]  http://cahs-acss.ca/wp-content/uploads/2015/07/ROI_FullReport.pdf. 
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